Literature DB >> 33802465

A Time-Based Meta-Analysis on the Incidence of New Onset Diabetes after Liver Transplantation.

Yip Han Chin1, Hon Qin Marcus Tan1, Cheng Han Ng1, Darren Jun Hao Tan1, Snow Yunni Lin1, Daniel Q Huang1,2,3, Chin Meng Khoo1,2, Mark Dhinesh Muthiah1,2,3.   

Abstract

NODAT (new-onset diabetes after transplantation) is an important complication after liver transplant, however, there is variation in the reported incidence of NODAT. Therefore, a meta-analysis was performed to estimate the incidence of NODAT in liver transplant. Electronic databases were searched for articles regarding NODAT incidence after liver transplantation. Incidence of NODAT were analyzed at six different timepoints. Summary statistics were calculated using a generalized linear mixed model in random effects. 28 articles were included and out of a pooled population of 71,257 patients, overall incidence of NODAT was found to be 15.51%, 16.09%, 18.30%, 20.86%, 18.08%, 25.05% for three-months, six-months, one-year, three-year, five-year, and ten-year timepoints respectively. After a sensitivity analysis which only included articles with clear definitions of NODAT, the incidence of NODAT was found to be higher at three-year (21.79%), five-year (25.82%), and ten-year (44.95%) timepoints. Subgroup analysis according to ethnicity found no significant differences for all timepoints. However, studies with predominantly Asian participants generally had a higher incidence of NODAT. In conclusion, this meta-analysis provides a pooled estimate of the incidence of NODAT following liver transplantation. Further studies are required to provide a more comprehensive understanding on how ethnicity can affect the incidence of NODAT.

Entities:  

Keywords:  NODAT; incidence; liver transplantation; new onset diabetes after transplantation; type 2 diabetes

Year:  2021        PMID: 33802465      PMCID: PMC7959476          DOI: 10.3390/jcm10051045

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  64 in total

1.  Association between E23K variant in KCNJ11 gene and new-onset diabetes after liver transplantation.

Authors:  Zahra Parvizi; Negar Azarpira; Leila Kohan; Masumeh Darai; Kourosh Kazemi; Mohamad Mehdi Parvizi
Journal:  Mol Biol Rep       Date:  2014-07-05       Impact factor: 2.316

2.  New-onset diabetes mellitus after living-donor liver transplantation: association with graft synthetic function.

Authors:  Shintaro Yagi; Toshimi Kaido; Taku Iida; Atsushi Yoshizawa; Hideaki Okajima; Shinji Uemoto
Journal:  Surg Today       Date:  2016-11-11       Impact factor: 2.549

3.  The association of hepatitis C virus infection and post-liver transplant diabetes: data from 17 000 HCV-infected transplant recipients.

Authors:  Z Younossi; M Stepanova; S Saab; G Trimble; A Mishra; L Henry
Journal:  Aliment Pharmacol Ther       Date:  2014-11-21       Impact factor: 8.171

4.  Long-term outcome of 'long-term liver transplant survivors'.

Authors:  Angel Rubín; Cristina Sánchez-Montes; Victoria Aguilera; Fernando San Juan; Isabel Ferrer; Angel Moya; Eva Montalva; Eugenia Pareja; Rafael López-Andujar; Martín Prieto; Marina Berenguer
Journal:  Transpl Int       Date:  2013-05-28       Impact factor: 3.782

5.  Corticosteroid-free immunosuppression in liver transplantation: a meta-analysis and meta-regression of outcomes.

Authors:  George Sgourakis; Arnold Radtke; Ioannis Fouzas; Sofia Mylona; Kostantinos Goumas; Ines Gockel; Hauke Lang; Constantine Karaliotas
Journal:  Transpl Int       Date:  2009-05-13       Impact factor: 3.782

6.  Early occurrence of new-onset diabetes after transplantation is related to type of liver graft and warm ischaemic injury.

Authors:  Hermien Hartog; Christine J H May; Chris Corbett; Angela Phillips; Jeremy W Tomlinson; Hynek Mergental; John Isaac; Simon Bramhall; Darius F Mirza; Paolo Muiesan; M Thamara P R Perera
Journal:  Liver Int       Date:  2014-11-20       Impact factor: 5.828

7.  New Onset Diabetes Mellitus in Living Donor versus Deceased Donor Liver Transplant Recipients: Analysis of the UNOS/OPTN Database.

Authors:  Anitha D Yadav; Yu-Hui Chang; Bashar A Aqel; Thomas J Byrne; Harini A Chakkera; David D Douglas; David C Mulligan; Jorge Rakela; Hugo E Vargas; Elizabeth J Carey
Journal:  J Transplant       Date:  2013-09-24

8.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

9.  Undue reliance on I(2) in assessing heterogeneity may mislead.

Authors:  Gerta Rücker; Guido Schwarzer; James R Carpenter; Martin Schumacher
Journal:  BMC Med Res Methodol       Date:  2008-11-27       Impact factor: 4.615

10.  Risk of de novo post-transplant type 2 diabetes in patients undergoing liver transplant for non-alcoholic steatohepatitis.

Authors:  Maria Stepanova; Linda Henry; Rishi Garg; Shirley Kalwaney; Sammy Saab; Zobair Younossi
Journal:  BMC Gastroenterol       Date:  2015-12-15       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.